XML 32 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Recognized compensation expenses
The Company recognized compensation expense related to the Company plans for the years ended December 31, 2019, 2018 and 2017 as follows (in thousands):
 
 
 
2019
 
2018
 
2017
Stock option plan expense
 
$
1,085

 
$
996

 
$
1,305

Restricted stock expense
 
$
21,260

 
$
21,053

 
$
18,539


Summary of the Activity of Stock Option Awards
A summary of the activity of the Company’s stock options plans is presented below:
 
 
 
Shares
 
Wtd. Avg.
Exercise
Price
 
Wtd. Avg.
Remaining
Contractual Term (years)
 
Aggregate
Intrinsic
Value
 
 
(In thousands)
 
 
 
 
 
(In thousands)
Options outstanding at January 1, 2019
 
1,462

 
$
24.30

 
7.20
 
$
924

Granted
 
391

 
22.68

 
 
 
 
Exercised
 
(78
)
 
16.03

 
 
 
 
Forfeited/Canceled
 
(185
)
 
24.60

 
 
 
 
Options outstanding at December 31, 2019
 
1,590

 
$
24.29

 
6.90
 
$
232

Options vested and expected to vest at December 31, 2019
 
1,521

 
$
24.34

 
6.82
 
$
232

Options exercisable at December 31, 2019
 
809

 
$
24.84

 
5.53
 
$
232


The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of 2019 and the exercise price, times the number of shares that are “in the money”) that would have been received by the option holders had all option holders exercised their options on December 31, 2019. This amount changes based on the fair value of the Company’s stock.
The following table summarizes information relative to stock option activity during the years ended December 31, 2019, 2018 and 2017 (in thousands):
 
 
 
2019
 
2018
 
2017
Intrinsic value of options exercised
 
$
433

 
$
519

 
$
4,126

Fair value of shares vested
 
$
971

 
$
794

 
$
373


Exercise Prices and Related Information of Stock Option Outstanding
The following table summarizes information about the exercise prices and related information of stock options outstanding under the Company plans at December 31, 2019:
 
 
 
Options Outstanding
 
Options Exercisable
Exercise Prices ($)
 
Number
Outstanding
 
Wtd. Avg.
Remaining
Contractual
Life
 
Wtd.  Avg.
Exercise
Price
 
Number
Exercisable
 
Wtd. Avg.
Remaining
Contractual
Life
 
Wtd.  Avg.
Exercise
Price
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
0-18.23
 
112

 
1.73
 
$
14.54

 
112

 
1.73
 
$
14.54

18.24-22.26
 
618

 
7.16
 
$
21.00

 
287

 
6.25
 
$
20.71

22.27-29.39
 
519

 
7.61
 
$
25.07

 
203

 
5.17
 
$
28.77

29.40-50.00
 
341

 
7.04
 
$
32.31

 
207

 
6.95
 
$
32.31

Total
 
1,590

 
6.90
 
$
24.29

 
809

 
5.53
 
$
24.84


Status of Non - Vested Stock Options
The following table summarizes the status of non-vested stock options as of December 31, 2019 and changes during the year ended December 31, 2019:
 
 
 
Number of Shares
 
Wtd. Avg. Grant
Date Fair Value
 
 
(In thousands)
 
 
Options non-vested at January 1, 2019
 
816

 
$
3.86

Granted
 
391

 
3.96

Vested
 
(241
)
 
3.55

Forfeited
 
(185
)
 
4.04

Options non-vested at December 31, 2019
 
781

 
$
3.99


Summary of the Activity of Restricted Stock
The following table summarizes the status of restricted stock awards as of December 31, 2019 and changes during the year ended December 31, 2019:
 
 
 
Shares
 
Wtd. Avg.
Grant  date
Fair value
 
 
(In thousands)
 
 
Restricted stock outstanding at January 1, 2019
 
2,018

 
$
27.62

Granted
 
788

 
23.79

Vested
 
(701
)
 
24.09

Forfeited/Canceled
 
(58
)
 
23.99

Restricted stock outstanding at December 31, 2019
 
2,047

 
$
27.33